1. Home
  2. TWST vs RXRX Comparison

TWST vs RXRX Comparison

Compare TWST & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$57.36

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.55

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWST
RXRX
Founded
2013
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.4B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
TWST
RXRX
Price
$57.36
$3.55
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$46.25
$7.50
AVG Volume (30 Days)
1.0M
10.6M
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
63.89
14.79
EPS
N/A
N/A
Revenue
$376,572,000.00
$74,681,000.00
Revenue This Year
$18.91
$12.11
Revenue Next Year
$15.07
$82.52
P/E Ratio
N/A
N/A
Revenue Growth
20.32
26.92
52 Week Low
$23.30
$2.80
52 Week High
$57.88
$7.18

Technical Indicators

Market Signals
Indicator
TWST
RXRX
Relative Strength Index (RSI) 67.03 58.15
Support Level $41.85 $2.98
Resistance Level N/A $5.03
Average True Range (ATR) 3.15 0.16
MACD 0.76 0.07
Stochastic Oscillator 93.81 95.33

Price Performance

Historical Comparison
TWST
RXRX

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: